Posted on Leave a comment

Cannabis & the Bible

Biblical scholars have written about the role of cannabis as a sacrament in the ancient Near East and Middle East. Archeological evidence confirms the use of the plant in fumigation rituals in ancient Israel. Scriptural references indicate that cannabis was a key ingredient in the holy anointing oil employed in religious rites. But Yahweh, the Almighty Jealous God, frowned upon the idolatrous use of cannabis, the polytheistic drug of choice. The Old Testament chronicles the embrace of One God instead of many, a major shift that coincided with the displacement of cannabis as a ceremonial substance, as Chris Bennett reports in his latest book, Cannabis: Lost Sacrament of the Ancient World.

Humankind’s connection to cannabis reaches back tens of thousands of years. The role of cannabis in the ancient world was manifold: with its nutritious seeds, an important food; with its long, pliable strong stalks an important fiber; as well as an early medicine from its leaves and flowers; and then there are its psychoactive effects . . .

Due to its usefulness, cannabis has a very long history of human cultivation. How long, exactly, remains unknown. “No other plant has been with humans as long as hemp,” says ethnobotanist Christian Rätsch. “It is most certainly one of humanity’s oldest cultural objects. Wherever it was known, it was considered a functional, healing, inebriating, and aphrodisiac plant. Through the centuries, myths have arisen about this mysterious plant and its divine powers. Entire generations have revered it as sacred . . . . The power of hemp has been praised in hymns and prayers.”

The Great Leap Forward

There has been interesting scientific speculation that the psychoactive properties of cannabis played a role as a catalyst in the “Great Leap Forward,” a period of rapid advancement for prehistoric humanity, which started about 50,000 to 65,000 years ago. In their fascinating paper, “The Evolution of Cannabis and Coevolution with the Cannabinoid Receptor — A Hypothesis,” Dr. John M. McPartland and Geoffrey W. Guy explain how ingestion of this plant may have aided prehistoric humans. “In a hunter-gatherer society,” they write, “the ability of phytocannabinoids to improve smell, night vision, discern edge and enhance perception of color would improve evolutionary fitness of our species. Evolutionary fitness essentially mirrors reproductive success, and phytocannabinoids enhance the sensation of touch and the sense of rhythm, two sensual responses that may lead to increased replication rates.”

The authors postulate that plant compounds, which interact with the human body’s endocannabinoid system, “may exert sufficient selection pressure to maintain the gene for a receptor in an animal. If the plant ligand [plant-based cannabinoid] improves the fitness of the receptor by serving as a ‘proto-medicine’ or a performance-enhancing substance, the ligand-receptor association could be evolutionarily conserved.” In essence they are suggesting that there’s a coevolutionary relationship between “Man and Marijuana” — and that somehow as we have cultivated cannabis, it may have cultivated us, as well.

Somehow as we have cultivated cannabis, it may have cultivated us, as well.

McPartland and Guy reference others who propose that cannabis was the catalyst that facilitated the emergence of syntactic language in Neolithic humans: “Language, in turn, probably caused what anthropologists call ‘the great leap forward’ in human behavior, when humans suddenly crafted better tools out of new materials (e.g. fishhooks from bone, spear handles from wood, rope from hemp), developed art (e.g. painting, pottery, musical instruments), began using boats, and they evolved intricate social (and religious) organizations . . . . This recent burst of human evolution has been described as epigenetic (beyond our genes) — could it be due to the effect of plant ligands?”

In his study on the botanical history of cannabis and man’s relationship with the plant, Mark Merlin, Professor of Botany at University of Hawaii, referred to hemp as one of “the progenitors of civilization.” Merlin was not alone in suggesting that hemp “was one of the original cultivated plants.” In The Dragons of Eden: Speculations on the Evolution of Human Intelligence, the late Carl Sagan conjectured that early man may have begun the agricultural age by first planting hemp. Sagan, who was known to have a fondness for cannabis himself, cited the pygmies from southwest Africa to demonstrate his hypothesis. The pygmies had been basically hunters and gatherers until they began planting hemp, which they used for religious purposes. The pygmies themselves profess that at the beginning of time the gods gave them cannabis so they would be both “healthy and happy.”

Gift of the Gods

Professor Richard E. Schultes, of Harvard University, considered the father of modern ethnobotany, believed it was likely in the search for food that humanity first discovered cannabis and its protein-rich seeds. Today, hempseed products are touted as a modern “super food” due to their richness in essential fatty acids.

“Early man experimented with all plant materials that he could chew and could not have avoided discovering the properties of cannabis (marijuana), for in his quest for seeds and oil, he certainly ate the sticky tops of the plant,” Schultes has written. “Upon eating hemp, the euphoric, ecstatic, and hallucinatory aspects may have introduced man to the other-worldly plane from which emerged religious beliefs, perhaps even the concept of deity. The plant became accepted as a special gift of the gods, a sacred medium for communion with the spiritual world and as such it has remained in some cultures to the present.”

Archaeological evidence attests to this ancient relationship as well. A hemp rope dating back to 26,900 BC was found in Czechoslovakia; it’s the oldest evidence of hemp fiber. Hemp fiber imprints over 10,000 years old in pottery shards in Taiwan, and remnants of hemp cloth from 8,000 B.C. have been found at the site of the ancient settlement Catal Hüyük in Anatolia (modern day Turkey). Much older tools for breaking hemp stalk into fibers indicate humanity has been using cannabis for cloth “since 25,000 B.C. at least,” according to prehistoric textiles expert Elizabeth Wayland-Barber.

Cannabis was also among our first medicines. A recent study by Washington State University scientist Ed Hagen suggests that our prehistoric ancestors may have ingested cannabis as a means of killing of parasites, noting a similar practice among the primitive Aka of modern-day central Africa. We do know that references to cannabis medicine appear in the world’s oldest pharmacopeias, such as China’s Shennong Ben Cao Jing, in ancient Ayurvedic texts, in the medical papyrus of Egypt, in cuneiform medical recipes from Assyria, first on a list of medicinal plants in the Zoroastrian Zend Avesta, and elsewhere.

Holy Smokes!

Evidence of cannabis being burnt ritually is believed to date as far back as 3,500 BCE based on archaeological finds in the Ukraine and Romania. In Incense and Poison Ordeals in the Ancient Orient, Alan Godbey attributes the genesis of the concept of “divine plants” to “when the primeval savage discovered that the smoke of his cavern fire sometimes produced queer physiological effects. First reverencing these moods of his fire, he was not long in discovering that they were manifested only when certain weeds or sticks were included in his stock of fuel. After finding out which ones were responsible, he took to praying to these kind gods for more beautiful visions of the unseen world, or for more fervid inspiration.”

Various Biblical scholars have written about the role of cannabis as a sacrament in the ancient Near East and Middle East. The ancient Hebrews came into contact with many cultures — the Scythians, Persians, Egyptians, Assyrians, Babylonians, and Greeks — that consumed cannabis. And these cultures influenced the Hebrew’s use of the plant in fumigation rituals and as a key ingredient in the holy anointing oil applied as a topical to heal the sick and reward the righteous.

There’s compelling evidence that in ancient Israel cannabis was used in fumigation rituals and as an ingredient in the holy anointing oil.

Compelling evidence of the ritual use of cannabis in ancient Israel was reported in a 2020 archaeological study, “Cannabis and Frankincense at the Judahite Shrine of Arad,” by the Journal of the Institute of Archaeology of Tel Aviv University. The authors noted that two altars with burnt plant residues had been found in a shrine at an ancient Hebrew outpost in tel Arad. One of the altars tested for frankincense, a well-known Biblical herb, and the other altar tested positive for cannabis resin.

The research, expectedly, caused a storm of controversy, with Biblical historians, religious authorities, and other parties weighing in. An article in Haaretz, headlined “Holy Smoke | Ancient Israelites Used Cannabis as Temple Offering, Study Finds,” raised a key question: “If the ancient Israelites were joining in on the party, why doesn’t the Bible mention the use of cannabis as a substance used in rituals, just as it does numerous times for frankincense?”

The Disappearance of “Kaneh Bosm”

Actually, several scholars have drawn attention to indications of cannabis use in the Bible. Polish anthropologist and etymologist Sula Benet contends that the Hebrew terms kaneh and kaneh bosm refer to cannabis. Benet identified five specific references in the “Hebrew Bible” (aka the Old Testament) — Exodus 30:23, Song of Songs 4:14, Isaiah 43:24, Jeremiah 6:20, and Ezekiel 27:19 — that mention kaneh and kaneh bosm. However, when one reads these passages individually and compares them, a stark contrast emerges.

In Exodus 30:23, the reference is to an ingredient in the Holy Oil, which was used in the Holy of Holies, the inner chamber of the Temple in Jerusalem, whereas in Jeremiah 6:20, this same previously sacred substance is wholly rejected as an item of foreign influence and disdain. It appears that Yahweh, the Jealous God, frowned upon the idolatrous use of cannabis, the polytheistic drug of choice.

The identity of kaneh and kaneh bosm has long been a topic of speculation. Benet’s view was that when the Hebrew texts were translated into Greek for the Septuagint, a mistranslation took place, deeming it as the common marsh root “calamus.” This mistranslation followed into the Latin, and then English translations of the Hebrew Bible. It should be noted that other botanical mistranslations from the Hebrew to Greek in the Hebrew Bible have been exposed.

Buy Book

This article is adapted from Cannabis: Lost Sacrament of the Ancient World by Chris Bennett (TrineDay, 2023). Bennett is the author of several books, including Liber 420 and Cannabis and the Soma Solution.

The post Cannabis & the Bible appeared first on Project CBD.

Original Article

Posted on Leave a comment

Which Terpenes Enhance the Cannabis High?

Ten years ago, most cannabis consumers couldn’t tell a terpene from a cannabinoid. But today things are different. Cannabis flower is categorized according to terpene profile. Product manufacturers add terp blends back into edibles and concentrates. Limonene is practically a household name.

And for good reason. Sure, terpenes impart desirable flavors and aromas. They appear to be good for the body, as well.1 Now it turns out that some terpenes also may contribute to the cannabis high.

A 2021 study2 by University of Arizona scientists concluded that certain terpenes are “cannabimimetic” (in a mouse model of cannabis intoxication) and can selectively enhance cannabinoid activity.

And this month comes a brand-new paper in the journal Biochemical Pharmacology3 by Israeli researchers who report that three cannabis terpenes — at concentrations similar to those found in actual cannabis plants — significantly boost THC signaling at the CB1 receptor.

CB1 Activation

Using an in vitro cellular model, the Israeli team compared CB1 receptor activation by 16 different cannabis terpenes to that of THC alone and to THC-terpene blends with a botanically relevant ratio of 10:1.

When tested individually, all 16 terpenes activated CB1, at about 10% to 50% of activation of THC alone. This is notable in and of itself, though not a huge surprise. While their chemical structures differ quite a bit, terpenes and cannabinoids share key features; both belong to a larger group of plant compounds called terpenoids. In fact, cannabinoids are technically classified as “terpeno-phenolic” substances.

Varying Responses

Next, the researchers tested terpenes and THC together. What they found runs the gamut. In the cases of beta-pinene and geraniol, the mixtures actually produced a smaller effect than the sum of the individual parts, as if these terpenes negated some of THC’s activity.

For eight of the THC-terpene blends, including some of the most common cannabis terpenes — alpha-pinene, beta-caryophyllene, bisabolol, eucalyptol, humulene, myrcene, nerolidol, and terpinolene — CB1 activation equaled that of THC alone. The presence of the terpene seemed to make no difference.

A 2021 study reports that some terpenes are “cannabimimetic” and can enhance cannabinoid activity.

But with three other terpene-THC blends — linalool, ocimene, and terpineol — the researchers observed an additive effect, meaning that CB1 activity equaled the sum observed with THC and the terpene separately. In other words, if the terpene was a 3 and THC was a 7, the blend was a 10.

Finally, three of the terpenes — limonene, borneol, and sabinene — produced a synergistic effect in combination with THC. In these cases, the whole was greater than the sum of its parts: an 11 or 12 rather than the expected 10.

THC-Terpene Synergies

The researchers consider this latter point their most significant finding. It represents the first demonstration of THC-terpene synergism in an in vitro controlled setting, and lends the paper its title: “Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation.”

Is this evidence of the fabled cannabis entourage effect? Strictly speaking, no, according to the paper’s authors. They note that the term “entourage effect,” as originally coined in a 1998 article in the European Journal of Pharmacology,4 refers to cases where compounds that don’t directly bind to CB1 or CB2 nonetheless boost the activity of the endocannabinoid system.

Since terpenes do activate CB1, this doesn’t fit with the original concept of the entourage effect. “Given that cannabis terpenes demonstrate direct agonism at CB1 receptor,” the authors contend, “THC-terpene effects are beyond the classical definition of entourage.”

Therapeutic Applications?

Semantics aside, the paper’s fundamental findings around THC-terpene interactions, at ratios similar to those in the cannabis plant and at very low terpene concentrations, could have significant implications for both future research and real-world cannabis use.

The simple fact that different terpenes can modify THC activity in different ways seems worthy of attention on its own, but the authors put particular emphasis on their discovery of a synergistic effect for limonene, borneol, and sabinene. While limonene is among the most common cannabis terpenes, borneol is less so, and sabinene is rarer still. As a result, they suggest that these terpenes could be intentionally added to cannabis extracts to maximize effectiveness of their THC content.

Terpenes could be added to cannabis extracts to maximize the effectiveness of their THC content.

“The use of selected terpenes may enable reducing the THC dose in some treatments, and as a result, potentially minimizing the THC-related adverse effects,” they conclude. “This would also help in adjusting the treatment to more sensitive populations such as children and elderly.”

The authors continue, “Enrichment with selected terpenes may allow for composition adjustment to personal needs and to changes during chronic use, such as for daytime versus for sleep.”

Of course, these statements are speculative and not necessarily supported by clinical research. They also smack a bit of marketing-speak, which is not surprising given that four of the authors are employees of the Bazelet Group, a medical cannabis manufacturer in Israel that boasts of using a “breakthrough technology” to “formulate specific desired [cannabinoid-terpene formulations] to supply enhanced therapeutic effect in various medical conditions.”

As always in cannabis science and medicine, the real world is far more complex than the lab, and preclinical findings don’t always translate into lived experience. But at the very least, the study provides further evidence of interactions between terpenes, cannabinoids, and the endocannabinoid system — something Project CBD will explore further in a subsequent article on beta-caryophyllene, the “super terpene.”

Nate Seltenrich, Project CBD contributing writer, is the author of the column Bridging the Gap. An independent science journalist based in the San Francisco Bay Area, he covers a wide range of subjects, including environmental health, neuroscience, and pharmacology. © Copyright, Project CBD. May not be reprinted without permission.

Footnotes

  1. Cox-Georgian, Destinney et al. “Therapeutic and Medicinal Uses of Terpenes.” Medicinal Plants: From Farm to Pharmacy 333–359. 12 Nov. 2019, doi:10.1007/978-3-030-31269-5_15
  2. LaVigne, Justin E et al. “Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.” Scientific reports vol. 11,1 8232. 15 Apr. 2021, doi:10.1038/s41598-021-87740-8
  3. Raz, Noa et al. “Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation.” Biochemical pharmacology vol. 212 (2023): 115548. doi:10.1016/j.bcp.2023.115548
  4. Ben-Shabat, S et al. “An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.” European journal of pharmacology vol. 353,1 (1998): 23-31. doi:10.1016/s0014-2999(98)00392-6

The post Which Terpenes Enhance the Cannabis High? appeared first on Project CBD.

Original Article

Posted on Leave a comment

Finding Rare Cannabinoids in Non-Cannabis Plants

Special glands protruding from cannabis flowers express a series of unique molecules. Cannabinoids, as they are known, exist in cannabis. But it turns out that identical molecules are present in non-cannabis plants, as well. Researchers from Israel’s Weizmann Institute recently reported that they found cannabigerolic acid (CBGA) and other rare cannabinoids in Helichrysum umbraculigerum, a perennial shrub informally known as the woolly umbrella.1

A South African Botanical

Ferdinand Bohlmann and Evelyn Hoffman first discussed the chemical irregularity of Helichrysum. In a 1979 paper published in Phytochemistry2, they analyzed the South African species H. umbraculigerum, native to the eastern part of the country, where it was used in traditional medicine and fumigation rituals.

Bohlmann and Hoffman asserted that the plant’s tops — both leaves and flowers — produce cannabis-specific compounds. But a follow-up study conducted by Italian researchers in 2017 failed to find CBG or its acidic precursor in H. umbraculigerum flowers. They did, however, identify an analog of CBG known as Heli-CBG (also present in some fiber hemp varietals), which binds to the CB2 cannabinoid receptor.3,4

In a May 2023 article in Nature Plants, Weissman Institute scientists confirmed that woolly umbrella produces CBGA in trichomes on its leaves, but hardly any CBGA was present on its flowers. That’s different from cannabis, where CBGA and other cannabinoids are concentrated in trichomes on flower tops.1

Trichomes found on cannabis inflorescence (flowers) have a special cellular build, according to a 2022 study by University of British Columbia researchers in Current Biology. The gland’s bulbous head holds large porous cells that let acidic cannabinoids (CBGA, CBDA, THCA, etc.) move through the trichome.5 The Weizmann Institute team reported that H. umbraculigerum produces a similar cannabinoid transport network on its leaves.1

Sourcing Rare Cannabinoids in Non-Cannabis Shrubs

How did the Israeli scientists figure this out? They fed woolly umbrella precursor compounds responsible for making cannabinoids in cannabis. When given two precursors (hexanoic acid and phenylalanine), the shrub produced more cannabinoids compared to plants fed regular nutrients. This means that the same biosynthetic pathway exists in both cannabis flowers and woolly umbrella leaves.

The woolly umbrella shrub naturally produces on its leaves over 4% cannabigerolic acid alongside other rare cannabinoids. The shrub also contains water-soluble cannabinoids, which are not found in cannabis.

The woolly umbrella shrub produces CBGA in trichomes on its leaves, but not on its flowers.

Essentially, two different plant species have developed the same machinery to produce CBGA. Yet, woolly umbrella is evolutionarily distinct from cannabis. And unlike the shrub, cannabis makes two unique enzymes that flip CBGA into either THCA and/or CBDA.

Exploring a New Phytocannabinoid Toolkit

Thus, there are two toolboxes for cannabinoid phyto-synthesis in the phylogenetic tree. Terpenes and a few flavonoids accompany lipophilic cannabis flowers, whereas a complex array of flavones and water-soluble cannabinoids develop in H. umbraculigerum. By understanding their similarities and differences, we can better assess the therapeutic potential of each plant.

Cannabinoid compounds found in woolly umbrella dissolve more easily in water and can target specific areas of the body, such as the deeper bowel. But greater bioavailability, an argument for water-soluble cannabinoids, is not necessarily equivalent to greater potency. That which is absorbed quickly and easily also leaves the body and loses efficacy faster. And cannabinoid receptors have more affinity for fat-loving compounds compared to water-soluble agonists.6,7

Travis Cesarone is a freelance writer and communicator focusing on medical cannabis sciences. © Copyright, Project CBD. May not be reprinted without permission.

References

  1. Berman, P., de Haro, L.A., Jozwiak, A. et al. Parallel evolution of cannabinoid biosynthesis. Nat. Plants (2023).
  2. Cannabigerol-ähnliche verbindungen aus Helichrysum umbraculigerum. Phytochemistry. 1979;18(8):1371-1374.
  3. Pollastro, F., De Petrocellis, L., Schiano-Moriello, A., Chianese, G., Heyman, H., Appendino, G., & Taglialatela-Scafati, O. (2017). Amorfrutin-type phytocannabinoids from Helichrysum umbraculigerum. Fitoterapia, 123, 13–17.
  4. Pollastro F, Taglialatela-Scafati O, Allarà M, Muñoz E, Di Marzo V, De Petrocellis L, Appendino G. Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa). J Nat Prod. 2011 Sep 23;74(9):2019-22. doi: 10.1021/np200500p. Epub 2011 Sep 8. PMID: 21902175.
  5. Livingston, S. J., Rensing, K. H., Page, J. E., & Samuels, A. L. (2022). A polarized supercell produces specialized metabolites in cannabis trichomes. Current biology : CB, 32(18), 4040–4047.e4. https://doi.org/10.1016/j.cub.2022.07.014
  6. Li, X., Chang, H., Bouma, J. et al. Structural basis of selective cannabinoid CB2 receptor activation. Nat Commun 14, 1447 (2023).
  7. Stadel, R., Ahn, K. H., & Kendall, D. A. (2011). The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. Journal of neurochemistry, 117(1), 1–18. https://doi.org/10.1111/j.1471-4159.2011.07186.x

Original Article